These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
624 related articles for article (PubMed ID: 33795647)
1. Regulated cell death pathways in doxorubicin-induced cardiotoxicity. Christidi E; Brunham LR Cell Death Dis; 2021 Apr; 12(4):339. PubMed ID: 33795647 [TBL] [Abstract][Full Text] [Related]
2. Dexrazoxane ameliorates doxorubicin-induced cardiotoxicity by inhibiting both apoptosis and necroptosis in cardiomyocytes. Yu X; Ruan Y; Huang X; Dou L; Lan M; Cui J; Chen B; Gong H; Wang Q; Yan M; Sun S; Qiu Q; Zhang X; Man Y; Tang W; Li J; Shen T Biochem Biophys Res Commun; 2020 Feb; 523(1):140-146. PubMed ID: 31837803 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic Targets for DOX-Induced Cardiomyopathy: Role of Apoptosis vs. Ferroptosis. Kitakata H; Endo J; Ikura H; Moriyama H; Shirakawa K; Katsumata Y; Sano M Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163335 [TBL] [Abstract][Full Text] [Related]
5. Astragaloside IV intervenes multi-regulatory cell death forms against doxorubicin-induced cardiotoxicity by regulating AMPKα2 pathway. Hu Y; Yu J; He W; Qiao Y; Cheng X; Huang H; Lai S; Yin D; He H Int Immunopharmacol; 2024 Dec; 142(Pt A):113078. PubMed ID: 39236461 [TBL] [Abstract][Full Text] [Related]
6. Spexin inhibits excessive autophagy-induced ferroptosis to alleviate doxorubicin-induced cardiotoxicity by upregulating Beclin 1. Ou W; Liu H; Chen C; Yang C; Zhao X; Zhang Y; Zhang Z; Huang S; Mo H; Lu W; Wang X; Chen A; Yan J; Song X Br J Pharmacol; 2024 Nov; 181(21):4195-4213. PubMed ID: 38961632 [TBL] [Abstract][Full Text] [Related]
8. A novel compound DT-010 protects against doxorubicin-induced cardiotoxicity in zebrafish and H9c2 cells by inhibiting reactive oxygen species-mediated apoptotic and autophagic pathways. Tang F; Zhou X; Wang L; Shan L; Li C; Zhou H; Lee SM; Hoi MP Eur J Pharmacol; 2018 Feb; 820():86-96. PubMed ID: 29229534 [TBL] [Abstract][Full Text] [Related]
9. Astragalus polysaccharide restores autophagic flux and improves cardiomyocyte function in doxorubicin-induced cardiotoxicity. Cao Y; Shen T; Huang X; Lin Y; Chen B; Pang J; Li G; Wang Q; Zohrabian S; Duan C; Ruan Y; Man Y; Wang S; Li J Oncotarget; 2017 Jan; 8(3):4837-4848. PubMed ID: 27902477 [TBL] [Abstract][Full Text] [Related]
10. Vagus nerve stimulation exerts cardioprotection against doxorubicin-induced cardiotoxicity through inhibition of programmed cell death pathways. Prathumsap N; Ongnok B; Khuanjing T; Arinno A; Maneechote C; Apaijai N; Chunchai T; Arunsak B; Kerdphoo S; Janjek S; Chattipakorn SC; Chattipakorn N Cell Mol Life Sci; 2022 Dec; 80(1):21. PubMed ID: 36583785 [TBL] [Abstract][Full Text] [Related]
11. Recent Advances in the Mechanisms of Cell Death and Dysfunction in Doxorubicin Cardiotoxicity. Wang TH; Ma Y; Gao S; Zhang WW; Han D; Cao F Rev Cardiovasc Med; 2023 Nov; 24(11):336. PubMed ID: 39076437 [TBL] [Abstract][Full Text] [Related]
12. Gasdermin D mediates endoplasmic reticulum stress via FAM134B to regulate cardiomyocyte autophagy and apoptosis in doxorubicin-induced cardiotoxicity. Qu Y; Gao R; Wei X; Sun X; Yang K; Shi H; Gao Y; Hu S; Wang Y; Yang J; Sun A; Zhang F; Ge J Cell Death Dis; 2022 Oct; 13(10):901. PubMed ID: 36289195 [TBL] [Abstract][Full Text] [Related]
13. Doxorubicin Blocks Cardiomyocyte Autophagic Flux by Inhibiting Lysosome Acidification. Li DL; Wang ZV; Ding G; Tan W; Luo X; Criollo A; Xie M; Jiang N; May H; Kyrychenko V; Schneider JW; Gillette TG; Hill JA Circulation; 2016 Apr; 133(17):1668-87. PubMed ID: 26984939 [TBL] [Abstract][Full Text] [Related]
14. Autophagy and mitophagy in the context of doxorubicin-induced cardiotoxicity. Koleini N; Kardami E Oncotarget; 2017 Jul; 8(28):46663-46680. PubMed ID: 28445146 [TBL] [Abstract][Full Text] [Related]
15. Doxorubicin induces cardiotoxicity through upregulation of death receptors mediated apoptosis in cardiomyocytes. Zhao L; Zhang B Sci Rep; 2017 Mar; 7():44735. PubMed ID: 28300219 [TBL] [Abstract][Full Text] [Related]
16. Effects of doxorubicin cancer therapy on autophagy and the ubiquitin-proteasome system in long-term cultured adult rat cardiomyocytes. Dimitrakis P; Romay-Ogando MI; Timolati F; Suter TM; Zuppinger C Cell Tissue Res; 2012 Nov; 350(2):361-72. PubMed ID: 22864983 [TBL] [Abstract][Full Text] [Related]
17. Differential impact of doxorubicin dose on cell death and autophagy pathways during acute cardiotoxicity. Kawalec P; Martens MD; Field JT; Mughal W; Caymo AM; Chapman D; Xiang B; Ghavami S; Dolinsky VW; Gordon JW Toxicol Appl Pharmacol; 2022 Oct; 453():116210. PubMed ID: 36028075 [TBL] [Abstract][Full Text] [Related]
18. Ghrelin inhibits doxorubicin cardiotoxicity by inhibiting excessive autophagy through AMPK and p38-MAPK. Wang X; Wang XL; Chen HL; Wu D; Chen JX; Wang XX; Li RL; He JH; Mo L; Cen X; Wei YQ; Jiang W Biochem Pharmacol; 2014 Apr; 88(3):334-50. PubMed ID: 24522112 [TBL] [Abstract][Full Text] [Related]
19. Iron metabolism in doxorubicin-induced cardiotoxicity: From mechanisms to therapies. Ye H; Wu L; Liu Y Int J Biochem Cell Biol; 2024 Sep; 174():106632. PubMed ID: 39053765 [TBL] [Abstract][Full Text] [Related]